Learn More
Ramaekers et al. [1] describe a review of the single technology appraisal [2] of Janssen-Cilag’s abiraterone acetate (tradename Zytiga ) plus prednisolone (AAP) in chemotherapy-naı̈ve metastatic(More)
presented in the guideline. A systematic review was performed on all the information about the dosage and frequency of administration found in the summary of product characteristics of the different(More)
  • 1